πŸ‡ΊπŸ‡Έ FDA
Patent

US 11248022

Glypican-3 peptide reagents and methods

granted A61KA61K47/55A61K47/62

Quick answer

US patent 11248022 (Glypican-3 peptide reagents and methods) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K47/55, A61K47/62, A61K47/6907, A61K49/0032